Matthew Starr
Nurse Practitioner · Kittanning, PANPI 1063486868
Payments from drug & device makers
What this record shows
Smith+Nephew accounts for 84.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,807 and has fallen 90.6% since, to $169 in 2025. Among nurse practitioner clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 28 payments — averaging $75.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Bioventus LLC$87
- Pacira Pharmaceuticals Incorporated$67
- Johnson & Johnson$37
- Endo Pharmaceuticals Inc.$36
- Heron Therapeutics, Inc.$31
- plus $69 from 3 others
Across 1 payment — averaging $10,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$10K
What the payments were for
- Travel & lodging$1,21357%
- Food & beverage$89843%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 12 | $1,783 |
| Bioventus LLC | 3 | $87 |
| Pacira Pharmaceuticals Incorporated | 4 | $67 |
| Johnson & Johnson | 2 | $37 |
| Endo Pharmaceuticals Inc. | 2 | $36 |
| Heron Therapeutics, Inc. | 1 | $31 |
| Vertex | 2 | $28 |
| Integra Lifesciences Corporation | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$2,589
- REAL INTELLIGENCE$1,546
- REDAPT$1,295
How this compares
$2,111 in reported general payments places this provider in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 124 | $8,507 |
| Celecoxib | 74 | $1,583 |
| Oxycodone Hcl | 185 | $1,118 |
| Cephalexin | 141 | $471 |
| Methylprednisolone | 59 | $367 |
| Gabapentin | 13 | $165 |
| Clindamycin Hcl | 41 | $154 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $94 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Kittanning
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
- Nicole WaetzmanStrafford$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.